BEBPA Blog
As part of BEBPA’s mandate to provide forums to foster scientific discussion among biopharmaceutical scientists, we actively write up the results of these discussions. These written updates come in the form of White papers written by a committee of scientists, the results of live interactive surveys and occasionally written reports by attendees. These reports are made available to the public and can be downloaded freely.
Robust Regression: An effective Tool for detecting Outliers in Dose-Response Curves
Volume 2, Issue 4: Outliers are abnormal values in a data set and are described as “inconsistent with the known or assumed data distribution” [1].
Tech Briefing: Bioassays For New Product Modalities
As a staring place, this is not a bad effort at defining new modalities. The widely varying product types highlights the scope of the problem
Reference Standards for Biosimilars
Volume 2, Issue 5: The importance of suitable reference materials for potency assays and other relative format assays in protein therapeutics cannot be overstated. Since
Reference Material Day 1 Panel Discussion
A transcript of the Day 1 “Question and Answer Session” from the BEBPA Virtual conference focused on Reference Material for late-stage clinical and commercial pharmaceutical
2025 USB Conference Survey Results (PDF)
BEBPA Blog 2025 USB Conference Survey Results (PDF) View PDF Survey
2025 RFM Conference Survey Results (PDF)
BEBPA Blog 2025 RFM Conference Survey Results (PDF) View PDF Survey
An Interview with BEBPA’s President: Laureen Little, Ph.D.
BEBPA had a chance to sit down with Laureen Little, the President of BEBPA and producer for the upcoming US Bioassay Conference happening March 24-26,
Unveiling Host Cell Protein (HCP) Coverage in Three-Dimensions (3D): Why It Matters and How to Achieve It
Host cell proteins (HCPs) are impurities derived from the host organism used in the production of genetically engineered biopharmaceuticals. Their removal is crucial for the
Beyond Potency: Leveraging Bioassays for Contaminant Testing
Volume 2, Issue 3: Bioassays are used extensively for potency determination of biologic therapeutics. However, ensuring the purity and safety of biologic drugs is of